Cell therapy weekly: job losses at Lonza and positive results in stage IV pancreas cancer
This week: autologous therapies shown to safe and tolerated in pancreatic cancer and type 1 diabetes trials, and new biopharma will develop candidate from MD Anderson Cancer Center.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.